Fitc conjugated goat anti mouse pab

Manufactured by Agilent Technologies

FITC-conjugated goat anti-mouse pAb is a polyclonal antibody that has been conjugated with the fluorescent dye FITC (Fluorescein Isothiocyanate). This antibody is specific to mouse antibodies and can be used for various immunodetection and immunolabeling applications.

Automatically generated - may contain errors

Lab products found in correlation

Rabbit igg isotype control, by Thermo Fisher Scientific (2 mentions) Isotype control mouse igg2a, by BD (2 mentions) A0136, by Agilent Technologies (1 mentions) A 21424, by Thermo Fisher Scientific (1 mentions) Mouse anti human cd11b apc cy7, by BD (1 mentions) Ba 1000, by Vector Laboratories (1 mentions) Mouse igg1 isotype control, by BD (1 mentions) Ba 9200, by Vector Laboratories (1 mentions) Anti cd14 pe, by BD (1 mentions) Hrp conjugated donkey anti rabbit igg, by GE Healthcare (1 mentions)

Close spelling variants of this product

FITC-conjugated goat anti-mouse Goat anti-mouse FITC Anti-TM

2 protocols using fitc conjugated goat anti mouse pab

Immunohistochemical Analysis of SAP, CRP, and C1q

Check if the same lab product or an alternative is used in the 5 most similar protocols

Rabbit anti-human SAP polyclonal antibody (pAb) (565191, Calbiochem), rabbit anti-human CRP pAb (235752, Calbiochem), rabbit anti-human C1q pAb (A0136, Dako), mouse anti-human complement component C5b-9 monoclonal antibody (mAb) (IgG2a) (011-01, Antibody Shop), mouse IgG1 isotype control (BD Biosciences), mouse IgG2a isotype control (BD Biosciences), rabbit IgG isotype control (Invitrogen), FITC-conjugated goat anti-rabbit pAb (F1262, Sigma-Aldrich), FITC-conjugated goat anti-mouse pAb (F0479, Dako), mouse anti-human CD45 FITC/CD14 PE (342408, BD Biosciences), mouse anti-human CD11b APC-Cy7 (560914, BD Biosciences), Alexa-555-conjugated goat anti-mouse IgG (A-21424, Thermo Fischer), biotinylated goat anti-rabbit IgG (BA-1000, Vector Laboratories), or biotinylated goat anti-mouse IgG (BA-9200, Vector Laboratories) are the commercial antibodies.

Pilely K., Fumagalli S., Rosbjerg A., Genster N., Skjoedt M.O., Perego C., Ferrante A.M., De Simoni M.G, & Garred P. (2017). C-Reactive Protein Binds to Cholesterol Crystals and Co-Localizes with the Terminal Complement Complex in Human Atherosclerotic Plaques. Frontiers in Immunology, 8, 1040.

+ Open protocol

+ Expand

Complement System Characterization Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols

The C3 inhibitor compstatin Cp40 was provided from Professor John D. Lambris (University of Pennsylvania) 20 .
Commercial antibodies: Rabbit anti-C3c polyclonal antibody (pAb) (DAKO, A0062), rabbit anti-C4c pAb (DAKO, Q0369), rabbit anti-C1q pAb (DAKO, A136), rabbit anti-IgM pAb (DAKO, A0425), rabbit anti-IgA pAb (DAKO, A0262), mouse anti-C5b-9 monoclonal antibody (mAb) (IgG2a) (Antibody Shop, 011-01), mouse-IgG2a isotype-control (BD Bioscience, M5409), rabbit-IgG isotype-control (Invitrogen, 10500C), FITC-conjugated goat anti-rabbit pAb (Sigma-Aldrich, F1262), FITC-conjugated goat anti-mouse pAb (DAKO, F0479), HRP-conjugated donkey antirabbit-IgG (GE Healthcare, NA934V), anti-CD14-PE (BD, 345785), and anti-CD45-FITC/anti-CD14-PE (BD, 342408).
In house produced antibodies: mouse anti-C4c mAb clone 99-72-18, mouse anti-C3bc mAb clone BH6, mouse anti-C9 mAb clone aE11, mouse anti-C6 mAb clone 9C4, and mouse anti-ficolin-2 mAb clone FCN219.

Pilely K., Bakke S.S., Palarasah Y., Skjoedt M.O., Bartels E.D., Espevik T, & Garred P. (2019). Alpha-cyclodextrin inhibits cholesterol crystal-induced complement-mediated inflammation: A potential new compound for treatment of atherosclerosis. Atherosclerosis, 283.

+ Open protocol

+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Revolutionizing how scientists
search and build protocols!